Atalanta Sosnoff Capital, LLC Abb Vie Inc. Transaction History
Atalanta Sosnoff Capital, LLC
- $4.43 Billion
- Q2 2024
A detailed history of Atalanta Sosnoff Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Atalanta Sosnoff Capital, LLC holds 322,555 shares of ABBV stock, worth $64.7 Million. This represents 1.25% of its overall portfolio holdings.
Number of Shares
322,555
Previous 466,537
30.86%
Holding current value
$64.7 Million
Previous $85 Million
34.88%
% of portfolio
1.25%
Previous 1.96%
Shares
15 transactions
Others Institutions Holding ABBV
# of Institutions
3,785Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.7 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.74 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $355B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...